2016 Discharge: European Medicines Agency (EMA)

This procedure concerns the 'discharge' of the European Medicines Agency's (EMA) budget for the 2016 financial year. This is a formal process where the European Parliament reviews how the agency spent its funds to ensure the money was used legally, efficiently, and for its intended purposes.

This affects the EMA's management and accountability. A positive discharge confirms that the agency's financial accounts are accurate and that its administrative operations meet EU standards.